FDA Reverses Decision, Allowing Amicus To File For Rare Disease Drug

Last November, tiny Amicus Therapeutics said that the Food and Drug Administration would not consider approving migalastat, a treatment for a rare disorder called Fabry disease. Today, Amicus says that the FDA is reversing the decision, and that there is a clear path to approval.

from Forbes Real Time http://www.forbes.com/sites/matthewherper/2017/07/11/fda-reverses-decision-allowing-amicus-to-file-for-rare-disease-drug/
via IFTTT